If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: BioPortfolio
Plexcera: Roivant and Plexcera spin out Farber disease biotech Enzyvant
Roivant Sciences and Plexcera Therapeutics have announced the formation of Enzyvant Sciences a new biopharmaceutical
Read full article »
Plexcera's Competitors
|
Plexcera's News
|
Plexcera's Financials
Follow
Followers on Owler
3
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO
Update CEO
CEO Approval Rating
- -/100
Read more
See Plexcera company profile »